Physician profile
Ernest A Bailey
NPI 1114985314
$978.58
in general payments reported to CMS, 2019-2025
21 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $112 · 2021: $76.58 · 2022: $57.66 · 2023: $241 · 2024: $120 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $207.36 | 2022-2025 | Azstarys |
| Sanofi Pasteur INC. | $103.67 | 2019-2024 | |
| Cranial Technologies, INC | $93.12 | 2019-2025 | Doc Band |
| Pfizer INC. | $70.54 | 2019-2023 | |
| Ironshore Pharmaceuticals INC. | $67.14 | 2019-2024 | Jornay Pm |
| Sobi, INC | $65.23 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $58.95 | 2019-2022 | |
| Neurelis, INC. | $41.05 | 2021-2023 | Valtoco |
| Tris Pharma INC | $38.45 | 2019-2025 | Onyda Xr |
| Astrazeneca Pharmaceuticals LP | $37.46 | 2021-2023 | Flumist Quadrivalent |
| Ars Pharmaceuticals Operations, INC. | $27.09 | 2025 | Neffy |
| Meridian Bioscience INC. | $22.08 | 2019 | |
| Supernus Pharmaceuticals, INC. | $20.45 | 2025 | Qelbree |
| Sanofi-Aventis U.S. LLC | $19.14 | 2025 | |
| Nestle Healthcare Nutrition INC. | $18.70 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $18.57 | 2023 | Crysvita |
| Kaleo, INC. | $15.85 | 2023 | Auvi-Q |
| Collegium Pharmaceutical, INC. | $15.73 | 2025 | Jornay Pm |
| Pharming Healthcare, INC. | $13.82 | 2023 | Ruconest |
| Arbor Pharmaceuticals, INC. | $12.99 | 2019 | |
| Genentech USA, INC. | $11.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ernest Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.